Vistance Networks (VISN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Announced definitive agreement to sell Connectivity and Cable Solutions (CCS) segment to Amphenol, expected to close in the first half of 2026, pending regulatory and shareholder approval.
Transaction aims to increase focus on ANS and RUCKUS businesses, unlock equity value, and return cash to shareholders.
Strong Q2 2025 financial results reported: net sales of $1.39 billion (up 31.7% YoY) and adjusted EBITDA of $338 million (up 79% YoY), marking five consecutive quarters of growth.
Raised 2025 adjusted EBITDA guidance to $1.15–$1.20 billion.
All business segments, including CCS, ANS, and RUCKUS, showed significant year-over-year growth in Q2 2025.
Voting matters and shareholder proposals
Sale of CCS segment to Amphenol is subject to shareholder approval as part of the transaction closing conditions.
Proxy materials and other relevant documents will be provided to shareholders for voting on the proposed transaction.
Board of directors and corporate governance
Directors, executive officers, and certain employees may be considered participants in the proxy solicitation for the transaction.
Information about directors and executive officers is available in the 2024 Annual Report and the March 2025 definitive proxy statement.
Latest events from Vistance Networks
- Director elections, executive pay, auditor ratification, and incentive plan shares up for vote.VISN
Proxy filing23 Mar 2026 - Proxy outlines director elections, executive pay, auditor ratification, and major ESG progress.VISN
Proxy filing23 Mar 2026 - Core adjusted EBITDA up 176% in 2025; $10/share special distribution planned.VISN
Q4 202526 Feb 2026 - Adjusted EBITDA up nearly 20% as CCS growth offsets declines; $2.1B OWN/DAS sale to aid liquidity.VISN
Q2 20242 Feb 2026 - Core adjusted EBITDA rose 25% on strong CCS gains; OWN and DAS divestiture set for Q1 2025.VISN
Q3 202416 Jan 2026 - Core adjusted EBITDA up 159% on 23.5% sales growth; 2025 guidance reaffirmed.VISN
Q1 202524 Dec 2025 - Q4 core sales jumped 27% and margins rose, with 2025 EBITDA guidance at $1.00–$1.05B.VISN
Q4 202421 Dec 2025 - CCS business sale unlocks equity, enables debt repayment, and sets up a major shareholder dividend.VISN
Proxy Filing1 Dec 2025 - $10.5B sale of CCS segment to Amphenol, pending approvals and board support.VISN
Proxy Filing1 Dec 2025